Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 12 March

Sam Kanaan
March 12, 2024

Morning Bell 11 March

Sam Kanaan
March 11, 2024

Weekly Wrap 8 March

Sophia Mavridis
March 8, 2024

Morning Bell 8 March

Sam Kanaan
March 8, 2024

Morning Bell 7 March

Sophia Mavridis
March 7, 2024

Morning Bell 6 March

Sam Kanaan
March 6, 2024

Morning Bell 5 March

Sam Kanaan
March 5, 2024

Morning Bell 4 March

Sophia Mavridis
March 4, 2024

Weekly Wrap 1 March

Grady Wulff
March 1, 2024

Morning Bell 1 March

Sam Kanaan
March 1, 2024

Morning Bell 29 February

Sam Kanaan
February 29, 2024